메뉴 건너뛰기




Volumn 32, Issue 5, 2003, Pages 217-220

Staphylococcus aureus meningitis with intermediate sensitivity to glycopeptides: Therapeutic indications;Méningite à Staphylococcus aureus de sensibilité intermédiaire aux glycopeptides: Implications thérapeutiques

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPEPTIDE;

EID: 0037425805     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (5)

References (12)
  • 1
    • 0030841073 scopus 로고    scopus 로고
    • Meticillin-resistant Staphylococcus aureus clinical strain with reduced vancomycine susceptibility
    • Hiramatsu K, Hanaki H, Ino T, Yabuta K, Ogfuri T, Tenover FC. Meticillin-resistant Staphylococcus aureus clinical strain with reduced vancomycine susceptibility. J Antimicrob Chemother 1997; 40: 135-6.
    • (1997) J Antimicrob Chemother , vol.40 , pp. 135-136
    • Hiramatsu, K.1    Hanaki, H.2    Ino, T.3    Yabuta, K.4    Ogfuri, T.5    Tenover, F.C.6
  • 2
    • 0035352181 scopus 로고    scopus 로고
    • Incidence of Staphylococcus aureus with reduced susceptibility to glycopeptides in two French hospitals
    • Reverdy ME, Jarraud S, Bobin-Dubreux S et al. Incidence of Staphylococcus aureus with reduced susceptibility to glycopeptides in two French hospitals. Clin Microbiol Infect 2001; 7: 267-72.
    • (2001) Clin Microbiol Infect , vol.7 , pp. 267-272
    • Reverdy, M.E.1    Jarraud, S.2    Bobin-Dubreux, S.3
  • 3
    • 0003192546 scopus 로고    scopus 로고
    • Le point sur la situation épidémiologique de Staphylococcus aureus de sensibilité diminuée aux glycopeptides en France
    • Allouch PY, Astragneau P, Aubry-Damon H et al. Le point sur la situation épidémiologique de Staphylococcus aureus de sensibilité diminuée aux glycopeptides en France. BEH 2000; 23: 97-9.
    • (2000) BEH , vol.23 , pp. 97-99
    • Allouch, P.Y.1    Astragneau, P.2    Aubry-Damon, H.3
  • 4
    • 0035133008 scopus 로고    scopus 로고
    • Vancomycine-intermediate and resistant Staphylococcus aureus: What the infectious specialist needs to know
    • Fridkin SK. Vancomycine-intermediate and resistant Staphylococcus aureus: what the infectious specialist needs to know. Clin Infect Dis 2001; 32: 108-15.
    • (2001) Clin Infect Dis , vol.32 , pp. 108-115
    • Fridkin, S.K.1
  • 5
    • 0032542911 scopus 로고    scopus 로고
    • First clinical isolate of vancomycine-intermediate Staphylococcus aureus in a French hospital
    • Ploy MC, Grélaud C, Martin CL de Lumley, Denis F. First clinical isolate of vancomycine-intermediate Staphylococcus aureus in a French hospital. Lancet 1998; 351: 1212.
    • (1998) Lancet , vol.351 , pp. 1212
    • Ploy, M.C.1    Grélaud, C.2    De Lumley, M.C.L.3    Denis, F.4
  • 6
    • 0035129428 scopus 로고    scopus 로고
    • First report of meticillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycine in Thailand
    • Trakulsomboon S, Danchaivijitr S, Rongrungruang Y et al. First report of Meticillin-Resistant Staphylococcus aureus with Reduced Susceptibility to Vancomycine in Thailand. J Clin Microbiol 2001; 39: 591-5.
    • (2001) J Clin Microbiol , vol.39 , pp. 591-595
    • Trakulsomboon, S.1    Danchaivijitr, S.2    Rongrungruang, Y.3
  • 8
    • 0033580208 scopus 로고    scopus 로고
    • Emergence of vancomycine resistance in Staphylococcus aureus
    • Smith TL, Pearson ML, Wilcox KR et al. Emergence of vancomycine resistance in Staphylococcus aureus. N Engl J Med 1999; 340: 493-501.
    • (1999) N Engl J Med , vol.340 , pp. 493-501
    • Smith, T.L.1    Pearson, M.L.2    Wilcox, K.R.3
  • 9
    • 0032977001 scopus 로고    scopus 로고
    • Staphylococcus aureus with reduced susceptibility to vancomycine isolated from a patient with fatal bacteriemia
    • Rotun SS, McMath V, Schoonmaker DJ et al. Staphylococcus aureus with reduced susceptibility to vancomycine isolated from a patient with fatal bacteriemia. Emerging Infect Dis 1999; 5: 147-9.
    • (1999) Emerging Infect Dis , vol.5 , pp. 147-149
    • Rotun, S.S.1    McMath, V.2    Schoonmaker, D.J.3
  • 10
    • 0034614298 scopus 로고    scopus 로고
    • Staphylococcus with reduced susceptibility to vancomycin: Illinois, 1999
    • Centers for Disease Control and Prevention. Staphylococcus with reduced susceptibility to vancomycin: Illinois, 1999. Morb Mortal Wkly Rep 2000; 351: 1165-7.
    • (2000) Morb Mortal Wkly Rep , vol.351 , pp. 1165-1167
  • 11
    • 0033870551 scopus 로고    scopus 로고
    • Outbreak of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in a Parisian Hospital
    • Guerin F, Buu-Hoï A, Mainardl LJ et al. Outbreak of Methicillin-Resistant Staphylococcus aureus with Reduced Susceptibility to Glycopeptides in a Parisian Hospital. J Clin Microbiol 2000; 38: 2985-8.
    • (2000) J Clin Microbiol , vol.38 , pp. 2985-2988
    • Guerin, F.1    Buu-Hoï, A.2    Mainardl, L.J.3
  • 12
    • 0034083041 scopus 로고    scopus 로고
    • Retrospective screening for heterogeneous vancomycin resistance in diverse Staphylococcus aureus clones disseminated in French hospitals
    • Chesnau O, Morvan A, El Solh N. Retrospective screening for heterogeneous vancomycin resistance in diverse Staphylococcus aureus clones disseminated in French hospitals. J Antimicrob Chemother 2000; 45: 888-890.
    • (2000) J Antimicrob Chemother , vol.45 , pp. 888-890
    • Chesnau, O.1    Morvan, A.2    El Solh, N.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.